QQ客服 官方微博 反馈留言

	The role of prophylactic use of low molecular weight heparin or aspirin in thromboembolic events in primary membranous nephropathy
	Zou, Peimei; Li, Hang; Cai, Jianfang; Li, Chao; Chen, Zhenjie; Li, Xuewang
	2019
卷号	41期号:1页码:623-628
关键词	Primary membranous nephropathy low molecular weight heparin aspirin thromboembolism arterial
ISSN号	0886-022X
DOI	10.1080/0886022X.2019.1635030
URL标识	查看原文
收录类别	SCIE ; PUBMED
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/6338401
专题	中国医学科学院 北京协和医学院
推荐引用方式 GB/T 7714	Zou, Peimei,Li, Hang,Cai, Jianfang,et al. The role of prophylactic use of low molecular weight heparin or aspirin in thromboembolic events in primary membranous nephropathy[J],2019,41(1):623-628.
APA	Zou, Peimei,Li, Hang,Cai, Jianfang,Li, Chao,Chen, Zhenjie,&Li, Xuewang.(2019).The role of prophylactic use of low molecular weight heparin or aspirin in thromboembolic events in primary membranous nephropathy.,41(1),623-628.
MLA	Zou, Peimei,et al."The role of prophylactic use of low molecular weight heparin or aspirin in thromboembolic events in primary membranous nephropathy".41.1(2019):623-628.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。